ClosedPublished 5 Feb 2024

Merck & Co., Inc. /
Prometheus Biosciences, Inc.

Merck acquired Prometheus Biosciences in 2023

Buy side: Merck & Co., Inc.
Buy sideMerck & Co., Inc.
Target: Prometheus Biosciences, Inc.
TargetPrometheus Biosciences, Inc.
Source · 5 Feb 2024Source-verified
Buy side: Merck & Co., Inc.
Buy sideMerck & Co., Inc.
Target: Prometheus Biosciences, Inc.
TargetPrometheus Biosciences, Inc.
01 / BuyerMerck & Co., Inc.
02 / TargetPrometheus Biosciences, Inc.
Source-verified
01

What happened

Merck & Co., Inc. acquired Prometheus Biosciences, Inc., a clinical stage biotechnology company, in June 2023.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Merck acquired Prometheus Biosciences in 2023

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Also stated

    The source this page is built from.

    Source-verified
  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.